RecruitingNot ApplicableNCT05658796

RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

Telemedicine-delivered Digital Cognitive Behavioral Intervention to Decrease Post-operative Opioid Use Among Patients Undergoing Total Knee or Hip Arthroplasty

Sponsor

University of Pittsburgh

Enrollment

150 participants

Start Date

Jan 27, 2023

Study Type

INTERVENTIONAL

Conditions

Anxiety Depression Depression Anxiety Depressive Symptoms Anxiety Disorders Mood Disorders

Summary

It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether an app-based mental health program called RXWell can reduce opioid use after knee or hip replacement surgery in patients who have higher-than-average levels of anxiety or depression before surgery. **You may be eligible if...** - You are over 18 years old - You are scheduled for an elective (planned) primary total knee or hip replacement at a UPMC hospital - You have moderate-to-high levels of anxiety and/or depression symptoms based on a standardized questionnaire (PROMIS T-score ≥ 60) - You own a smartphone or tablet **You may NOT be eligible if...** - Your surgery is not elective, or it is a revision (repeat) surgery - You have active delirium, severe cognitive impairment, or severe intellectual disability - You do not have access to a smart device - You have active serious alcohol or drug use problems - Your mood disorder is very severe and requires immediate intensive treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORAL+RxWell

During the SuRxgWell trial, if a participant is randomized to receive RxWell, they will be provided with an access code that is required to download the app. Once the participant has downloaded the app, they will be paired with a UPMC coach who will guide the person through the sessions using in-app texting to help give them the tools needed to actively cope with anxiety and/or depression. The UPMC coaches are supervised by a licensed UPMC mental health clinician. The participant will have access to the app and coach for six months after they have consented. The digital behavioral tool includes over 30 brief Cognitive Behavioral Therapy (CBT) and mindfulness-based techniques.

BEHAVIORAL-RxWell

Treatment as usual